Eaton Vance Management’s Eli Lilly & Co Position
Does Eaton Vance Management own Eli Lilly & Co (LLY)? Yes — 3.33M shares worth $1.1B (+1.60% of its 13F portfolio) as of Q3 2022, down from 3.51M shares the prior filed quarter.
Position Value
$1.1B
Q3 2022
Shares
3.33M
% of Portfolio
+1.60%
Quarters Held
16
currently held
Position History LLY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2022 | 3.33M | $1.1B | +1.60% |
| Q2 2022 | 3.51M | $1.1B | +1.60% |
| Q1 2022 | 3.66M | $1.0B | +1.21% |
| Q4 2021 | 3.57M | $981M | +1.23% |
| Q3 2021 | 3.48M | $800M | +1.11% |
| Q2 2021 | 3.33M | $765M | +1.03% |
| Q1 2021 | 3.27M | $612M | +0.91% |
| Q4 2020 | 3.22M | $543M | +0.86% |
| Q3 2020 | 3.08M | $506M | +1.03% |
| Q2 2020 | 3.08M | $506M | +1.02% |
| Q1 2020 | 3.29M | $456M | +1.11% |
| Q4 2019 | 3.16M | $415M | +0.81% |
| Q3 2019 | 3.05M | $337M | +0.74% |
| Q2 2019 | 6.02M | $723M | +0.81% |
| Q1 2019 | 2.97M | $386M | +0.88% |
| Q4 2018 | 3.06M | $354M | +0.92% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Eaton Vance Management’s full portfolio or all institutional holders of LLY.